Search results
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
Zacks via Yahoo Finance· 5 days agoMerck MRK boasts more than six blockbuster drugs in its portfolio, with PD-L1 inhibitor Keytruda...
Merck’s MilliporeSigma agrees to acquire Mirus Bio for $600m
Pharmaceutical Technology via Yahoo Finance· 2 days agoMerck KGaA’s Life Science business in the US and Canada, MilliporeSigma, has entered a definitive...
Merck KGaA to buy gene therapy tools maker for $600M
BioPharma Dive via Yahoo Finance· 2 days agoDive Brief: German drugmaker Merck KGaA agreed to buy Mirus Bio for $600 million to build expertise in a critical part of viral vector-based gene therapy...
Merck & Co., Inc. (NYSE:MRK) is a favorite amongst institutional investors who own 79%
Simply Wall St. via Yahoo Finance· 3 days agoKey Insights Institutions' substantial holdings in Merck implies that they have significant...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 17 hours agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
McKesson, Merck back Atropos Health’s $33M round to accelerate drug development with AI
VentureBeat· 1 day agoAtropos Health, a healthcare technology company focused on generating personalized real-world...
Fed Inflation Gauge, Key Earnings Highlight Investing Action Plan
Investor's Business Daily· 12 hours agoLate in the week, the Fed's favorite inflation gauge, the core PCE price index, will be on tap....
Merck & Co Inc (MRK) Sits And Waits For Direction At $131.30 Price – Stocks Register
Stocks Register· 2 days agoMerck & Co Inc (NYSE:MRK) at last check was buoying at $131.30 on Thursday, May 23 with a rise of 0.15% from its closing price on previous day. Taking a look at stock we notice ...
Dow Jones Futures: Market Rally Narrows; Dow Giants Lead 7 Stocks Near Buy Points
Investor's Business Daily· 11 hours agoThe Dow Jones and Russell 2000 had solid losses as consumer, housing, commodity and software names...
Merck KGaA Buys Mirus Bio for $600 Million
Market Watch· 2 days agoBy Ian Walker Germany's Merck KGaA is buying life-science company Mirus Bio for $600 million as it expands its life science business sector. The...